Wilms' tumor 1 mutation accumulated during therapy in acute myeloid leukemia:: biological and clinical implications

被引：27

作者：

Nyvold, C. G. ^{[1
]}

Stentoft, J.

Braendstrup, K.

Melsvik, D.

Moestrup, S. K.

Juhl-Christensen, C.

Hasle, H.

Hokland, P.

机构：

[1] Aarhus Univ Hosp, Dept Hematol, DK-8000 Aarhus, Denmark

[2] Aarhus Univ, Dept Med Biochem, Aarhus, Denmark

[3] Skejby Hosp, Dept Pediat, Aarhus, Denmark

来源：

LEUKEMIA | 2006年 / 20卷 / 11期

关键词：

D O I：

10.1038/sj.leu.2404389

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2051 / 2054

页数：5

共 9 条

[1] Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients [J].

Cilloni, D ;

Gottardi, E ;

De Micheli, D ;

Serra, A ;

Volpe, G ;

Messa, F ;

Rege-Cambrin, G ;

Guerrasio, A ;

Divona, M ;

Lo Coco, F ;

Saglio, G .

LEUKEMIA, 2002, 16 (10) :2115-2121

[2] Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia -: A Europe Against Cancer Program [J].

Gabert, J ;

Beillard, E ;

van der Velden, VHJ ;

Bi, W ;

Grimwade, D ;

Pallisgaard, N ;

Barbany, G ;

Cazzaniga, G ;

Cayuela, JM ;

Cavé, H ;

Pane, F ;

Aerts, JLE ;

De Micheli, D ;

Thirion, X ;

Pradel, V ;

González, M ;

Viehmann, S ;

Malec, M ;

Saglio, G ;

van Dongen, JJM .

LEUKEMIA, 2003, 17 (12) :2318-2357

[3] Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance [J].

King-Underwood, L ;

Pritchard-Jones, K .

BLOOD, 1998, 91 (08) :2961-2968

[4]

Miyagawa K, 1999, GENE CHROMOSOME CANC, V25, P176, DOI 10.1002/(SICI)1098-2264(199906)25:2<176::AID-GCC14>3.3.CO

[5]

2-6

[6] AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1. [J].

Nishida, S ;

Hosen, N ;

Shirakata, T ;

Kanato, K ;

Yanagihara, M ;

Nakatsuka, S ;

Hoshida, Y ;

Nakazawa, T ;

Harada, Y ;

Tatsumi, N ;

Tsuboi, A ;

Kawakami, M ;

Oka, Y ;

Oji, Y ;

Aozasa, K ;

Kawase, I ;

Sugiyama, H .

BLOOD, 2006, 107 (08) :3303-3312

[7] WT1 gene expression:: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients -: results from a single-centre study [J].

Ostergaard, M ;

Olesen, LH ;

Hasle, H ;

Kjeldsen, E ;

Hokland, P .

BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (05) :590-600

[8] Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia [J].

Pallisgaard, N ;

Hokland, P ;

Riishoj, DC ;

Pedersen, B ;

Jorgensen, P .

BLOOD, 1998, 92 (02) :574-588

[9] Minimal residual core binding factor AMLs by real time quantitative PCR - Initial response to chemotherapy predicts event free survival and close monitoring of peripheral blood unravels the kinetics of relapse [J].

Stentoft, J ;

Hokland, P ;

Ostergaard, M ;

Hasle, H ;

Nyvold, CG .

LEUKEMIA RESEARCH, 2006, 30 (04) :389-395

← 1 →